Company Number: 13833566

Analysis Date: 2025-07-29 14:15 UTC

Financial Health Assessment for ORCA RENEWABLES LIMITED

---

1. Financial Health Score: B

Explanation:
The company demonstrates solid improvement in its liquidity and working capital position over the latest financial year, indicating a recovery from previous tight conditions. While it shows healthy net current assets and increasing shareholder funds, the relatively modest share capital and limited cash reserves suggest some caution. Overall, the company's financial "vital signs" reflect a stable but still developing health profile, meriting a B grade.

---

2. Key Vital Signs

Metric	2024 Value	Interpretation
Current Assets	£79,905	Represents short-term resources available; decreased from prior year but still adequate.
Cash at Bank	£9,044	Cash reserve is positive but relatively low; indicates limited liquid buffer.
Debtors	£69,861	Significant receivables suggest ongoing sales but also risk of delayed payments.
Current Liabilities	£31,088	Debts due within one year significantly reduced from previous year; positive sign.
Net Current Assets	£48,817	Strong positive working capital indicating ability to meet short-term obligations.
Shareholders Funds	£48,817	Equity has grown substantially, reflecting retained earnings and capital, a mark of net worth.
Share Capital	£200	Very small; typical for small private companies, but may limit capacity to raise funds internally.
Employees	2	Small workforce, consistent with micro/small company classification.

---

3. Diagnosis (What the Numbers Reveal)

• Healthy Cash Flow "Pulse":
  The company shows a positive net current asset position, a critical "heartbeat" indicating it can cover short-term debts comfortably. This is a strong sign of liquidity health and operational stability.

• Receivables "Symptom":
  The large debtor balance, while a sign of ongoing business, could be a symptom of slower cash collection or credit risk. This requires monitoring to avoid liquidity strain.

• Reduced Short-Term Debt "Recovery":
  The significant reduction in current liabilities from £169,729 to £31,088 over the year suggests improved management of payables and possibly better cash management strategies.

• Equity Growth "Strength":
  The near quadrupling of shareholders' funds from £12,732 to £48,817 indicates retained profits or capital injections, providing a stronger financial "immune system."

• Limited Cash Reserves "Warning":
  Cash balances are modest relative to liabilities and sales, meaning the company should maintain vigilance over cash flow to avoid potential liquidity "crises."

• Small Share Capital "Limitation":
  The nominal share capital (£200) limits internal capital-raising capacity, meaning the company may rely on external financing or retained earnings for growth.

---

4. Recommendations (Treatment Plan)

• Improve Debtor Management:
  Accelerate collection processes or tighten credit terms to reduce days sales outstanding. This will strengthen cash inflows, improving liquidity "vitality."

• Increase Cash Reserves:
  Build up cash buffers through prudent cash flow forecasting and cost control, to protect against unexpected expenses or downturns.

• Monitor and Manage Payables:
  Continue the positive trend of reducing short-term liabilities, negotiating favorable payment terms with suppliers to optimise working capital cycles.

• Consider Capital Injection:
  If growth or investment is planned, explore options for increasing share capital or secured borrowing to enhance the financial "immune response."

• Regular Financial Reviews:
  Maintain frequent internal financial health checks to detect early signs of distress, akin to regular medical check-ups, enabling timely interventions.

• Plan for Scaling:
  With only two employees, ensure operational capacity matches business demands without overextending resources, maintaining sustainable growth.

---